Atlas Trials

PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.

Clinical trial NCT06815172 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06815172
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Pancreatic Adenocarcinoma
Start date
2020-05-28
Primary completion
2025-09-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.